Menu Back to Clinical-Trials-Regulations-Conference

Overview

While the implementation date of the Clinical Trial Database is delayed, work is progressing on the implementation of the Clinical Trial Regulation in other areas. The Clinical Trials Conference will focus on the differences between the present and new requirements for managing clinical trials in the face of forthcoming changes.                                                                                                                 

This conference will provide a forum for information exchange on both conceptual and practical questions of:

  • How will the new legislation change the processes and the format of the trial application?
  • What are the impacts on how a clinical trial is managed after approval has been granted?
  • What are the critical issues affecting sponsors and Member States
  • How will the new provisions for public access to an EU Clinical Trials Database enforce disclosure of clinical trial data and information?

Attendees will participate in the collaborative discussions through lectures, panel discussions and interactive sessions.

Experience the Conference on the go with the DIA Global App
DIA is going green: what about you?

In 2018, DIA is going paperless. No printed programme will be distributed onsite, so please make sure to download the app in advance.
The DIA Global App is designed to enhance your meeting experience and provide valuable information in one place. Search "DIA Global" in your app store.

  • View agenda and speakers
  • Connect and network with attendees and exhibitors
  • Participate in live session polling
  • Participate in live activity feed with real-time updates
  • Integrate with your social media accounts

Who should attend?

  • Regulatory agencies (assessors, reviewers, inspectors)
  • Sponsors of non-commercial clinical trials
  • The pharmaceutical industry and contract research organisations, including:
    • Regulatory affairs personnel in clinical research
    • Professionals in charge of clinical trial strategy
    • Regulatory intelligence and policy professionals
    • Change managers for clinical trials business processes
    • Clinical research professionals working with submission, data, information sharing
    • Clinical safety professionals

Learning objectives

  • Understand the new requirements along with the practical and operational considerations for implementation by authorities and clinical trial sponsors
  • Identify the key challenges and opportunities of the new requirements and policies
  • Leverage insights on how companies and research institutions are fine-tuning and optimising processes to meet the requirements of the Clinical Trials Regulation
  • Exchange views between regulators, clinical trial sponsors, patients, and other stakeholders

Program Committee

  • Nick  Sykes, MS
    Nick Sykes, MS Senior Director, Worldwide Safety & Regulatory
    Pfizer Ltd., United Kingdom
  • Surendra  Gokhale, PhD
    Surendra Gokhale, PhD Senior Director, Global Regulatory Affairs and Capability Development Lead
    F. Hoffmann-La Roche Ltd, Switzerland
  • Elke  Stahl, PhD
    Elke Stahl, PhD CTFG Co-Chair; Clinical Trial Unit
    Federal Institute For Drugs and Medical Devices (BfArM), Germany
  • Rose-Marie  Swallow
    Rose-Marie Swallow Senior Manager, EU Regulatory Policy & Intelligence
    Bayer plc., United Kingdom
Load More

Digital Learning Catalog

DIA Learning: 2018 eLearning Soultions
Download